发明名称 |
Solid Solution Compositions and Use in Chronic Inflammation |
摘要 |
The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions. |
申请公布号 |
US2016317482(A1) |
申请公布日期 |
2016.11.03 |
申请号 |
US201615195623 |
申请日期 |
2016.06.28 |
申请人 |
Infirst Healthcare Limited |
发明人 |
Bannister Robin M.;Brew John;Reiley, III Richard R.;Caparros Wanderley Wilson |
分类号 |
A61K31/192;A61K47/44;A61K31/196;A61K31/12;A61K47/14;A61K47/22 |
主分类号 |
A61K31/192 |
代理机构 |
|
代理人 |
|
主权项 |
1. A solid solution pharmaceutical composition comprising:
a) one or more propionic acid derived non-steroidal anti-inflammatory drugs (NSAIDs) in an amount of about 1% to about 35% by weight of the pharmaceutical composition; b) one or more pharmaceutically-acceptable hard fats comprising one or more glycerolipids in an amount of at least 30% by weight of the pharmaceutical composition; c) one or more pharmaceutically-acceptable monoglycerides in an amount of at least 30% by weight of the pharmaceutical composition, and wherein the solid solution pharmaceutical composition is formulated to have a melting point temperature of about 25° C. or higher. |
地址 |
London GB |